GIP: Glucose-Dependent Insulinotropic Peptide - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

GIP: Glucose-Dependent Insulinotropic Peptide

This study is ongoing, but not recruiting participants.
Information provided by National Institute on Aging (NIA)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00239707

Locations


United States, Maryland
	National Institute on Aging, Clinical Research Branch
	Baltimore, Maryland, United States, 21225

Sponsors and Collaborators

National Institute on Aging (NIA)

Investigators


Principal Investigator:	Josephine Egan, MD	Chief, Diabetes Section, National Institute on Aging